Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 484
  • Home
  • Print this page
  • Email this page
Cover page of the Journal of Health Sciences
ORIGINAL ARTICLE
Year : 2021  |  Volume : 14  |  Issue : 2  |  Page : 260-264

Emerging crisis of multidrug-resistant enterococci from a rural tertiary care hospital of North India


1 Department of Microbiology, SHKM, GMC, Nalhar, Nuh (Mewat), Haryana, India
2 Department of Microbiology, NMCH Jamuhar, Sasaram, Bihar, India

Correspondence Address:
Dr. Jyoti Sangwan
Associate Professor, Department of Microbiology, SHKM, GMC, Nalhar, Nuh (Mewat), Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/kleuhsj.kleuhsj_392_20

Rights and Permissions

INTRODUCTION: Enterococci are emerging as a major pathogen causing a variety of hospital-acquired nosocomial infections and community-acquired infections contributing significantly to patient's morbidity and mortality. The emergence of multidrug-resistant enterococci worsens the problem as multidrug resistance leaves fewer therapeutic options for clinicians in treating life-threatening infections. MATERIALS AND METHODS: This was an observational study carried out from March 2019 to February 2020. Antimicrobial susceptibility testing of enterococci was done by Kirby–Bauer disc diffusion method, and results were interpreted as per the Clinical and Laboratory Standards Institute guidelines 2019. RESULTS: Multidrug-resistant enterococci were reported to be 62.7%. A variable antimicrobial susceptibility pattern was seen with different antibiotics. Majority of isolates were resistant to β-lactam (96.6%), and high-level aminoglycoside resistance was seen in 39% of isolates. Glycopeptide resistance was observed in teicoplanin (14.6%). No vancomycin and linezolid resistance was noted. CONCLUSION: The prevalence of multidrug-resistant enterococci was reported to be 63%; the resistance was more common in Enterococcus faecium as compared to Enterococcus faecalis. This study highlights the emergence of multidrug-resistant enterococci, especially to high-level aminoglycoside and glycopeptide which poses a serious therapeutic challenge.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed62    
    Printed0    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal